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Abstract
This study

invesc~gaLed

the efficacy of currenL

medication treatment procedures for chronic schizophreniss
on neuropsychological measures .

A total of cwenty

parc:cipants from the Coles County
who

me~

DSM-:V criteria for chronic

Men~a:

Health Center,

schizop~renia ,

volunteered to be admi nistered the Wisconsin Card Sorting
Test (WCST)-64 card version as a means of assessing
neuropsychological executive functioning .

A total of

cwenty participants free of any diagnosable psychological
disorder also volunteered to be administered the WSCT - 64 ,
which served as a control group .

The staff psychiatrist at

tne Coles County Mental Healch CenLer compleced the
?osicive and Negative Syndrome Scale ( PANSS ) in order co
deLermine the
~arLicipant

predomi~ant

symptom presentacion of each

who had been diagnosed with schizophrenia .

Particip2nt ' s current dosage levels of Lypical and atypical
medication were recorded and analyzed following che
completion of

tesLi~g .

~esulcs

indicaced that cnly one

index of the WCST-64 could be predicced by medicacion type
a~d

the

combi~ed

relacionship of symptom presentation and

medicacion on tne
small sample size.

wcs~ - 64

ccu~a

noc be

compu~ea

due co
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Chapter I
Introduction
Our modern day conceptua lization of the psychological
construct known as schizophrenia has experienced an
algorithmic expansion since the coinage of the term in
1911 .

Eugen Bleuler , a Swiss psychiatrist , first proposed

that schizophrenics posses a dysfunctional dichotomy
between thought and emotion that is seen exclusively among
its sufferers .

A current taxonomy is offered in the

Diagnostic and Statistical Manual of Mental Disorders :
Fourth Addition , and staces that symptoms must be preser.t
signi:icantly over the cou r se of one month , some of which
must be present for at least a six month period .
Characteristics of schizoph r enia are manifested
typically as a mi xture of positive (excess or distortion of
funccioning ) and or negative (diminished or loss of
functioning)

symptomatology which may significantly impair

social , interpe r sonal , domestic , and occupational pursuits .
Crow (1980) and Kibei ,

Laf~ont ,

& Liddle (1993) state thac

negative symptoms include poverty

Be~k,

as diminished
Lucas , &

ir.terperso~al

Mactso~

~997).

chought and

activ~~y ,

blunted affect , decreased mocor
we~l

o~

speec~ ,

avolicion , as

interaction (as ciced in

Kay & Opler ( 1987 ) scate

that positive symptoms include delusions , hallucinat ions ,

A
and

ccncep~ua:

1997 ) .

~europsychclogical

disorganization (a s

ci~ed

perspect i ve 4

in Berk et . al

Diagnoses of subtype (i . e . p a ranoid , catatonic , and

diso r ganized) are spe c i fied contingent upon the predomi n ant
sympcom manifes:ation of the sufferer .
Alchough, as of now , chere appears to be no known cure
for schizophrer.ia the advent of

moder~

medicine has

provi ded sufferers wi t h ne w hope fo r i mp roved daily
functioning .

It has been suggested t hat newer medication ,

which have an affinity for dopamine - 2 (02)

recepcor blockage

and act as serotonin a ntagonists , are the most the
efficacious mechod o f s ymptom manageme nt and treatmen t
(Al exa nder (:996) and Stahl (1999)) .
report and observation have been
u~ili ~ y

Tradicionally , s e l f to ascercain the

u~ilized

and efficacy of psychcc=opic

study atcempced co p r ovide insi;ht

medica~ion .

in ~ o

This

the ef fec~s of

medica tion treatment wh i le employing a commonly used
neuro?sychological measure o= execuLive funcLioning .

Neuropsychological pa radigms and testing materials have
teen found to differentiate che strengths and weakness of
suffers of neurologica l deficits and provide a profile of
(Golden ,

Golds~ein ,

&

neuropsycho~ogical

proced~res

a~e

cortical :Lnction s
Al~~ough

wichin
for

~he

~escing

field ccd2y , they are
rnedicacion efficacy .

o:~ en

!nc~g~oli

~986 ; .

commonly used

cve~:ooked

as

~ools

A

~europsycholog~cal

perspec~ive
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CHAPTER I=
Rev~ew

of Literature

Researchers over the past several decades have worked
diligently to uncove r conclusive empirical evidence
regarding biological or environmenLal substrates
conLribuLing co the
crippling disorder .

etiol~gy

and progression of

th~s

The research in the area cf

schizoptrenia and information processing has been focused
on identi:ying
deeper
1996) .

~nsighL

c~gni~~ve

deficits which may provide us wi:h

into this psychological construct (Green

CogniLive de fi cits found among schizophrenics

appe ar to be varied due to of the heterogeneity betwe en , as
well as

with~n,

each subgroup .

collectively perform poorly on

However , schizophrenics
v~rLually

cognitive abi:ity (Green 1996) .

a~~

measures c:

There appear to be two

distinct types of cogn itive deficits underlying this

disorder :

those that arc

that emerge as a

resul~

ccncra~

to

~he

d~sorder

of psycho:ic episodes or

and cnose
Lhe

effects of psychoLropic medicaLicr.s {Green 1996) .
Dif:eren~iation
funcL~On~ng

scud~es

of Lhese two forms of deficits in cognitive

may be test ur.derscood when

are employed chat

exclcsive:y curing

del~neate

psyc~ocic

lcngit~dinal

de~~c~cs

9~~senL

episodes from those thaL are

stable Lhroughouc the course of the

i:~ness .

The latter

A
may serve as

"c ogn itiv~

~europsychological

perspecci7e 6

markersn for subsequent psychoLiC

episodes (Van Der Does eL . al 1993) .

A wide rarige of

information processing deficics may be found during
prodromal and residual stages .
Van Der Does et . al ( 1993 ) looked at groups of chronic
schizophrenics and compared measures of information
processing to groups of depressed participants

wit~out

schizophrenia and control participants (those free of
clinical diagnosis) .

They found chat differences occurred

between groups with regards to the type of information
processing skills which contributed to problem- solving
ability .

Specifically , it was found that the schizoph=enic

group showed significant impairment in molecular
information

processi~g

(i . e . reaction time ,

release , backwcrd masking , and vigilance) .
concluded from this

s~udy

reaction time
Ic was

that , " social cognitive problem

solving is associated with

sustai~ed

attencion among

individuals with a mood disorder and with a liberal
response style among indi7iduals with schizophreniau

( !:'
"

.

19) .

In general ,

findings in che area of

ci ~ nical

neuropsychology have lead to tne propositian that
schizophrenia is associac2d with
la~er~lized

dysfu~cLion ,

subcor~ica:

le:t hemisphere

dysfunction ,

cie:ici~

and

A

neu~opsychological perspec~ive
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overactivation , impaired interhemispheric integraticn , and
frontal dysfunction (Craft , Levin ,

& Yurgelun 1989) .

The

use of neuropsychological testing paradigms have been
instrumental fer researchers examining these areas of
d e ficit among schizophrenics .
Neuropsychological deficits are impairments in brain
functioning that may inhibit behavior and various degrees
of psychological functioning .

Measures designed to assess

these impairments attempt to address behavior deficits and
allow admi nistrators to make inferences regarding
dysfunct i on in corresponding cort i ca l and subcortical
regions of the brain .

Psychological i mpairments related to

brain dysfunct i on are typically measured by using
standardized tesLing procedures .

Neuropsychological

assessme nt procedures a r e an extension and quantification
of part of the neurologic examination concerned with higher
cortical functioning (Golden , Goldstein ,

& Incagnoli l986 ) .

The benefit of neuropsychological assessment over some
classical medical

neurologica~

procedures is that they

appear to be more sensitive to cognitive and personality
changes .

These forms of tesLing batteries

different~~Le

che strengths and weaknesses of sufferers of
neuropsyc~ological

cortical

f u nc~ions

de£~cits

a nd orc vide a profile

(Golden et. al 1986 ) .

It has been suggested
significant cognitive

tha~

de:~cits ,

chroni~

which are evident in

performance on cognitive - based tests .
Dickerson , & Ringel (1991)

Bcronow ,

schizophrenics show

A study conducted by

investigated the

relationship between neuropsycholosical deficits among
chronic schizoph renics regarding symptom manifestation and
found that the deficits that were found co be correlated
with predominant symptom manifestation were memory and
intellectual processes .
Impairment in voluntary and involuntary motor contro:
are o:ten observed in chronic schizo9hrenic patients
et .

a~

1989 ) .

Neuropsycho~ogical

( Cr==~

measures that assess

motor ability in schizophrenics routinely find a range o:
impairments from motor deficits of simple tasks , such as
finger tapping and manual dexterity , to complex

percept~o -

motor tasks , such as reaction time (Craft et . al 1989) .
Crc~tcr

visuomotor deficits have been found in

schizophrenics with primarily r.egative s;rnptoms than
schizophrenics with

a:

::..989 } .

fronta~

primari~y

~nc.erpretaticn

positive

sym~toms

o: tr.ese :ir.aings

l obe impairment found in

i~

(:raft st .

s~gges~s

sch~= o phrenics

wi:h

predominant: nega':ive symptoms may· disrupt: c.nei..c aoili;:.\.:
organize visuoconstructional

tas~s

<cra!L

e~ .

al 1989) .

~'.)
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(1988) and Lawson et . al

fraustman et. al
found no significant

(1988)

relationship between predominant

symptoms manifestation and neuropsychological deficits ir.
chronic schizophrenics , however these findings may be
difficult to interpret because the participants were
unmedicated at the time of testing (as
al 1991) .

ci~ed

in Boronow

e~ .

Both studies found that memory ar.d intellectual

processes were impaired among chronic schizophrenics
regardless of predominant symptom manifestation .
Several neuropsychologically based studies with
chronic schizophrenics have focused on observations of
abnormal speech processes .

Abnormal speech patterns of

schizophrenics strong ly resembles

Wern~cke's

aphasia, which

may suggest brain dysfunction of the left temporal lobe
(Cra ft et . al 1989) .

However , no significant impairment of

elementary language functions , i . e . naming and repetition
has been found .
Memory dysfunction found in schizophrenics suggests
neuropathological changes in medial l imbic
the temporal lobe
1989) .

higher

includin~

struc~ures

, era£~

the hippocampcs

It has been suggested by Luria ( l966 i ,
cor~ical

functions in patients

brain injury leads to significant
learning , affecting the

quali~y

~it~

cha~ges

and

of

et . al

t~at

loss of

a lccalized
~r.

char3cte~

~~e

p~ocess

of the

of

A

neuro9syc~olcgica:
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results cbtained in relation LO memcry processes ( as cited
in Berg et . al 1982) .

The study of memory processes with

schizophrenics has largely focused on ascertaining whether
or not distinctions exist between encoding and retrieval
processes, verbal and visual memory, and free recall and
recognition memory . The functional consequences of memory
impairment may foster a diminished capacity for appropriate
social skill acquisition , problem solving , and overall
information processing .
Actention deficits in schizophrenia are chought to

be

both a clinical symptom and underlying mechanism of other
cognitive dysfunctions (Craft et . al 1989) . One theory of
attention deficit in schizophrenia is that sufferers are
incapable of selectively attending to certain stimuli .
Another theory staces that the slowing of neurocognitive
functioning in schizophrenia correlates with attentional

deficits (Craft et . al 1989) . It is imperative chat , due to
the complex naLure of the various aspects of attention,
researchers o perationally define this

consc r~ ct

in their

scudies .
Pref r ontal lobe dysfunction in
been recognized .

schiz ophr ~nia

However, variabilicy

sxis~s

has long

among

sufferers in thac not all exhibi t dysfunccicn to che same
degree .

Walsh ( 1985) states Lhat cognicive

defic~ts

A

~europsychclogical

mediated by pref rontal lobe funcLioning are

pers9ecti7e .,
L~ose

th2t

allow an individual , " LO respond and adapt appropriately tc
his or her environment "
345) .

(as cited in CrafL et al ,

1989 , µ .

These cogniti ve processes collective ly designa Le

whaL are commonly referred to as executive functioning and
are ofLen found to be impoverished among schizophrenics .
Although e x ecutive fu n ctions ar e widely be li eved to be
mediated by the pre: r ontal lobe s , it is po ss ible that other
bra~n

corcical and subcorLical
these proces ses .

SLructures conL=ibuLe LO

Fo r this rea son , che use of the te rm

executive appea=s to be more accurate than what was
corrunonly r e f erred to as prefrontal functioning .
Seve ra l studies t h a t have i mp le mented
neuropsychological tescing procedu r es with s chizophren i cs
have found

impairmen~

in frontal lobe

funcLio~ing .

Ko ~ o

and Whishaw (1983) f ound that me as ures of r i ght - and lefL
f~ontal

and temporal functions suggested

signi=ica~~ly

impairment i n schizo p h r enics than controis

more

(as cited i n

Cra:t et . al 1989) .
I: is suggested in
:~vel ,

dS

rega~dless

o:

i~L=l~~?e~ce

that schizoph r enics perform poorly on the Wisconsin

CarL Sorting Test
place

gene=a~ .

h~gh

well as

(WCST) .

The WCST has been suggested co

demands on func:ions
i~s

o~

che

coordina Lion with che

pre~roncal

~imbis

svstern

co=~ex ,
rncs~:y

A

~e~r0psycnological perspec~~ve
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regarding the amygdala and the hippocampus (Harvard Mental
Health Letter , 1999) .

Most notably found in performances

among schizophrenics are signs of perseveration , which is
believed to be an , "inability to change

expec~ations

and

adopt to new information" (Harvard Mental Health Letter ,

1999) .

Certain negative symptomatic behavior of

schizophrenia manifested as blunted affect , emoLional
withdrawal , lack of spontaneity , and loss of drive parallel
Lhe apathetic syndrome of the prefrontal lobe (Berk et al .
1997) .

Pref rontal dysfuncLion has been found to be more

strongly correlated with negative symptom manifestation
than with positive symptom manifestation .

Specifically ,

schizophrenics with predominantly negative symptom
manifestations presented deficiencies in the iniLiation ,
planning, and organization of material , difficulties in
shifting cognitive set , recent memory impairment , and
slowed rate of learning and on slowing of thought (Berk et
al 1997) .

They suggest that , in regards to anatomical

SLructures, such dif:iculties correlate with deficits of
the dorso-lateral and medial prefrontal areas .
Results from
(MRI)

st~dies

using magnetic resonance

i~agir.g

indicate structural anomalies of the prefrJnLal

cortex in schizophrenics (Berk eL al . 1997) .

Br3in scans

taken while testing schizophrenics on behaviors

media~ed

by

t:he prefrontal corLex,

i~aica:e

c~ac

correspcnd~n~

structures are unable to meet requirements of the task and
that blood flo w appears to be lo wer Lhan normal in t:his
region (Harvard Mental Health Letter ,
curre~:

Alchough at the
k~own

cime

~999 ) .

t~ere

appears t:o be no

cure for the pervasive cognicively - degeneraLive

disorder referred to as schizophrenia , new methods of
symptom management and r elapse prevention have caught the
attention of many res earchers and health care professionals
during the end of che

LWentiet~

century .

It is imperacive

that treatment surrounding the schizophrenic population
must consider the heterogeneity among its suffers .

Kane

and McGlashan (1995) state that the most pragmatic
therapeutic approach in effectively treating chronically
disabled persons is by , "integrating drug and psychosocial
treat:ments" (p . 820) .
Deficits in social functioning are commonly exhibited

in schizophrenics and appear co be pervasive
various scages of illness .

throughou~

Methods of remediation are

frequently employed to improve

c~e

i~poverished

levels cf

psychosocial functioning of the schizophrenic sufferer .
Specialized programs have been design ed
s=hizopnreni=s on a ranee
basic convecsacion ,

the

o~

speci~ic

interperso~al

~0

train

sk~::s ,

" inc:~d~~g

problem solving , and
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medication managemenc " (Corrigan , Green ,
1994} .

Sc~ade ,

& Wallace

Psychosocial treatment programs are typically

designed so that skilled professionals develop an
environment that is conducive to social skill enhancement
by facilitating role plays regarding target behaviors ,
offering constructive feedback for client participation ,
and by offering reinforcement for successive approximations
Corrigan et .

of a target behavior (Corrigan et . al 1994) .

al (1994) state that research in the area of treatment for
psychosocial deficits in schizophr enics have found that
many participants , " improve their repertoire of
interpersonal and coping behaviors "

(p . 6) .

The majority of outpatient psychosocial rehabilitation
services available for sufferers of schizophrenia address
improving interpersonal skills , community integration and
provide vocational training opportunities .

Ofcen times

structured and mon i cored housing is integrated into a

patient ' s comprehensive treatment plan .

One major

advantage of the use of specialized psychosccial
rehabilicacion programs is , "avoiding inscicutionali=acion
with its learned dependence and

tru~cating

che l o ss of

healthy mental capacity and ccping skills ( Kane &
1995 )

•II

McGlasha~

A

ne~ropsychological

The advancement of modern psychoLropic medication has
provided researchers with a richer

co nceptual:zat~on

of

t his mind crippling psychiatric disorder as wel l as
offering promise for the prognosis of

i~s

suff2rers .

The

advent of antipsychot i c medication has contributed to a
greater understanding of the aetiology ,

as well as the

pathophysiology of schizophrenia ( Kane & McGlashan 1995)
The spotlight on pharmaceutical agents f or the treatment o:
major psychoses has shifted from traditional or " typical "
medications such as haloperidol and chlorpromazine to the
progressive " atypical " agents such as clozap:ne and
risperidone .

It is suggested that the new atypical

pharmaceuticals , offer efficacy in positive symptoms
(hallucinations , delusions , suspiciousness and persecution ,
agitation , and conceptual disorganization ) and in negative
symptoms (flat affect , emotional withdrawal , apathy ,
anhedon i a , and alogia)

(Alexander 1996) .

Of most

importance is that the new ly discovered atypicals provide
efficacy for negative symptom manifestation , whi ch is

~OL

found in older cypical agents .
Typi cal medications , otherwise known as
" conventional " , vary in poLency and d egree of side-effecL
inducement ; however , iL is believed that all are effective
in reducing psychocic symptoms , specifically positive

A neuropsycho:ogical pers9ect i ve :6
symptoms due to thei r af:inity fo r dopamine - 2 (02)
(Stahl 1999) .

recepcors

It appears that typical medication provides

efficacy in controlling posicive symptoms of schizo9hrenia
by acting a s an antag o nist in syn aptic sites of the
mesolimbic dopamine p a thway , wh i ch projects from the
ventral tegmental a=ea through t he medial

forebr~i~

bundle

to the amygdala , the lateral septum , the b e d nucleus of the
stria

termina~is ,

the hippocampu s, and the nucleus

accumbens (Carlson 1995) .

Stahl (1999)

sta~ed

tha: ,

" b lockage of posts y n ap tic do pamine r ece p to rs in the
mesolimb i c pathway is thought to mediate the antipsycho:ic
efficacy of the antipsychotic drugs , and

t~eir

ability to

diminish or block po s i t ive psyc h otic symptoms u (p . 38) .
Unfortunat e ly ,

typical or conventional medication may also

produce undesirable s : de - ef fect s such as extrapyramida l
symptcms (EPS) and tardive dyskinesia , wh i ch are a product

of the 02 blocking properties of these medications .
Extrapyramidal symptoms are produced by blockage of
receptors i n the nig r ostria:al dopamine pathway (which
project from che substantia nigra and
basal ganglia) .

The

~igros:r:acal

termi~ate

:r.

:he

dopamine pathway is part

of the extrapyramidal neurona: system of the

centr~l

nervous system , and olockage o= associaced dcpamine
receptors produces disorder of movement referred to as

A

~europsychclogica:

extrapyramidal symptoms (Stahl 1999) .

perspective 17

When dopamine

receptors in the nigrostriatal pathway are blocked for a
significant length of t i me , the irreversible hyperkinetic
disorder known as tardive dyskinesia may be a result .
Interestingly , typical medication may also produce
side - effects that resemble the negative symptoms of
schizophrenia . Such side - effects occur when typical
medication blocks

dopami~e

receptors in the mesocortical

pathway (which begins in the ventral tegmental area and
terminates in areas of the frontal and pref rontal lobes , as
well as in the limbic cortex , and hippocampus

(Carlson

1995) .
It is believed that the more recently developed
atypical medications differ from that of traditional
typical medicacion on three levels of e f ficacy .

Stahl

(1999) states that atypical medication differs from typical
medication producing little or no cxtrapyramidal symptoms

or tardive dyskinesia , by not raising

prolactin levels

like traditional typical medications , and by having greacer
efficacy for controlling negative symptoms ove r typical
medication .

Oi most relevance to cne currenc SLudy is tne efficacy
of the progressive acypical

med~sation

on controlling the

deficiency er receptors in the mesoccrtical dopamine

A
pachway ,

wh~ch

neuropsycho~cgica:

mediates negative symptom

is believed that the

ef~icacy

perspect~ve

ma~ifestation .

-~

... ...-

of atypical medication in

controlling negative symptom manifestation is due to their
pro9erties of being both a serotonin and dopamine
antagonis:. .

Stahl ( 1999 ) staces tha:. another hypothetical

cause of the negative symptoms of schizophrenia, other than
primary deficiency of dopamine in the mesocortical pathway ,
is that of secondary deficiency of "dopamine in the
mesocortical pathway as a result of serotonin excess "
57) .

(p .

It is believed that serotonin opposes or inhibits the

release of dopamine and

tha~

agents with antagonistic

serotonin propensity wil l consequently produce an increas e
of do9amine by disinhibition .
over typical

med~catior.

The e =: icacy of

a~ypical

in treating the negati·1e symptoms

of schizophrenia is the result of the

seroton~n-dopamine

antagonistic properties which have the capacity to increase
dopamine release selectivity in the rnesocortical pathway
(St:ahl :.999 ) .
The current study atcempted to provide fu=cher insight
in:.c the efficacy of medication
schizophrenia .

cf the r.ewly

for chronic

Of particular interest, was the influence

discov3~ed

atypica:

traditional typical medicacion
:or

trea~ment

schizo~hr~nics

~ha~

express

~edica:.i o ns

ori

exec~~ive

predomi~ar.:. l y

e ver the
: u nctioninq
more negative
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symptom manifestations .

It is hypothesized in general ,

based on previous empirical support (Berk Lucas , & Mattson
1997) , that those who possess predominantly more negative
symptom manifestations will perform significant ly worse on
measures of executive functioning than those that posses
predominantly positive symptom manifestations regardless of
medication type .
~hose

Specifically , it is hypothesized that

participants who posses predominantly more negative

symptom manifestations , and whose treatment involves higher
levels of typical medication , will perform significant ly
worse on measures of executive functioning when

compared

to participants with similar predominant negative symptom
manifestations whose treatment involves higher levels of
atypical medications .

The latcer hypothesis is based on

empirical support (Stahl 1999) suggesting the efficacy of
atypical medication on negative symptom

man~festation .

It

has been suggested that atypical medicution shows greater
par~ly

efficacy for negative symptom manifestations
dddressing deiiciencias in che
pathways which have termination
prefrontal

cor~e x .

meso - ccr~ical
si~es

by

dopami~e

in :he frontal and

Also suggested is that such

deficiencies may result in impoverished executive
function~ng,

thus it may be

levels of dopamine in

hypothes~zed

~he prefr~n~al

tha~

cor~ex

increased

(~esult~r.g

f~om

A neuropsychological
atypical
~xecutive

medica~ion

use) could influence

functioning .

perspec~ive

measur~s

The current study differs

orevious studies by employing

20

of
~rom

a neuropsychological measure

of executive functioning in attempts to delineate
predominant symptom manifestation and medication

~reatment .

It is hoped that the contribution of this study may lead to
subsequent research on medication efficacy regarding the
use of neuropsychological testing paradigms and to add
empirical support to the ever- developing conceptualization
of this psychological construct .

A neuropsychological perspecLiVe
CHAPTER I I
Method
Participants
Par~icipants

were drawn from the Coles County Mental

Health Center and were members of a specialized community
mental health rehabilitation program .

All participants

used in the sample met DSM- IV criteria for schizophrenia ,
regard~ess

of subtype ( Undifferentiated N= 7 ,

Paranoid N=

7 , Schizoaffective N= 5 , Residual N= 0 , and 1
undetermined) .

A total of 20 participants diagnosed with

schizophrenia who ranged in age from 30 - 66 years
48 . 55 , SD

=

old(~

=

9 . 24) and with 8 to 13 years of education

volunteered =or this study .
A cor.Lrol group of participants from the community

free of any diagnosable psychological disorder volunteered
for this study in order to strengthen the validity of the

testing procedures .
were

selec~ed

A total of 20 control participants

whose ages ranged from 18 - 57 years old (M

27 . 60 , SD = 10.09)

~ith

=

11 to 17 years of education .

Materials
The

c~rrent

study used the Wisconsin Card Sorting

Test - 64 Card Version
functioning .

(WCST-64) to measure executive

Currently there are no studies that

the validicv of Lhe WCST-64 .

However Heaton,

de~ermine

Iverson,
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Kon~s ,

and Thompson ( 2000 ) state that since this version

and previous versions have the same task requirements and
is derived from the same sample population , much of what
has been found from the earlier versions will generalize to
the current version .

The new WCST ( 64 card version) was

chosen over older versions due to its shorter
administration time , which was considered to be beneficial
due to deficits o: attention span often found among
schizophrenics

( Cra:~

et . al 1989, and Carpenter , Gold,

Goldberg, Randolph, & Weinberger 1992 } .
The WCST-64 is a widely used test of executive
functioning in which participants are given a pack of 64
cards which cor.tain as few as one and as mar.y as four
different syrneols : triangle, star , cross, or circle in
eithe r red , green , yellow , or blue .

There are no cards

that are identical regarding shape o r color .

Lezak (1983)

states that this task requires the participant to , "place

[cards] one by cne
triangle, two

u~der

gr~en

four

s~ars ,

sti~ulus

cards -- one red

three yellow crosses, and four

blue circles-acccrd:.ng co a principle that the patient must
deduce from the

pa~:erP-

if the examiner ' s response to the

pa-i:.2..ent' s p l acemen'.:. o: ;:ne -:ards" ( 9 .
basis fer

sor~~ n g

:s

i~

regaras co

number , back t o color , and so on .

~8 8) .

co~or,

cher. f:rm,

Participants are

g~ven

~

feedback

af~er
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each trial informing them whecher or not

Lheir response was correct and principles for matching are
changed after 10 correct responses .

The test is terminaLed

when the participant attempts 64 trials or achieves six
correct categories .

Scores generated by the WCST - 64 for

clinical pur9oses include : perseverative errors ( PE) , which
represent the number of errors in which a parcicipant
responds incorrectly while using the same response pattern ;
nonperseverative errors (NE) , which represent the number of
responses that are incorrect which do not met criteria as
perseveracive errors ;

total number of errors (TE) , which

represents the sum of perseverative and nonperseverative
errors ; categories completed (CC) , i n wh i ch i s scored by
t~e

number cf times a participant scores 10 consecutive

items ; failure to maintain set

( fM ) , which represents a

partic i pants inability to complete a category a:ter
successfully completing at lease 5 crials within the same
sorcing principle ; and conceptual level
represents
groups of
responsesu

consecut~ve
~hree

~2sponses

(CL) , which

that are " correct in

or mor: divided by the tocal number of

( Bell et . al 1995 ) .

It is suggested that a poor

oerformance o n the WCST indicates difficulty in sorting
regarding catego rical
of

ins~rucc i ons,

whi2h may be indicati7e

a n impaired abilicy to form concepts .

Pa=~icipan~s

with

A
particula~ly

~europsychclogical

perspective 24

left frontal lobe damage involving the medial

area often exhibit such diminished capacity (Lezak 1983) .
I~

general , the WCST - 64 assesses the executive or " frontal "

functioning of

planning , organization , cognitive

flexibility in shifting set , working memory , and inhibition
of impulsive responding (HeaLon et al . 2000) .

It has been

found Lhat the perseverative response score has achieved,
"the best diagnostic accuracy, correctly classifying 74% cf
the total impaired group and 72% of the normals " in the
initial normat i ve sample (Mitchell , 1985 , p . 1746) .

In

general , it is believed tnac the WCST - 64 is mosc accurace
in differentiating between pat ie nts with focal frontal
lesions and has long

bee~

found to be beneficial in

diagnosing neurological problems (Mitchell 1985) .
The ?ositive and Negative Syndrome Scale (PANSS) was
used as an indicator of predominant symptom manifescation
among

participants .

determi~es

The 2ANSS consists of 29 items which

the presence of positive (items 1 , 4 , 5 , 6 , 17 , 22,

and 23) , negacive (items 7,8 , 3, 10 , 11 , l5 , and 16) and
general sympccms (i cems 2,3 , 12 , 13 , 14 , 18 , l9 , 20 , 21 ,
24 , 25,26,27 , 28 , ana 29) 0f the
Scc~es

items

par~icipan:'s

disorder .

are ob-ca ined by, "si..:mming the sc8res of individual
composin~

each

com~onenc

cognitive, hos=ility , and

[positive, negaLive ,

emc~ional

discomfort]

{Bell et .
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al 1995)

•

Examples of positive symptoms reported on the

II

PANSS include "delusions " and " hallucinations " .

Negative

symptom examples include the presence of "passive withdraw"
and

" blun~ed

af ~ect ", and general symptom examples include

"preoccupation " and "motor retardation ". Predominant
symptom manifestation will thus be evident by considering
the number of co .: -responding symptoms in each component .
Procedure
All participants were

admi~istered

the

Wisconsi~

Card

Sorting Task (WCST - 64) when they were clinically stable on
neuroleptic medication and cooperative and compliant to
testing instrucLions to assess levels of executive
funcLioning .

The testing environment consisted of a

private room within the psychosocia:
facilities .

rehab~litation

Each participant received a two dollar

monetary incentive(non-contingenc upon Lheir completion of

the WCST-64)
study .

Personal demographic information regarding

mec~cation,
obta~!!ed

for their volunteering to participate in this

cu=~ent

upon

age , education ar.d diagnosis was

perm~ssion

The Positive 3nd

Negat~ve

completed by the staff
st:udy'

~

-ori.:nar.";
-

gran~ed

from each

par~icipant .

Syndrome Scale ' PANSS ) was

psychia~r~s~

and was returned to

fo.:.i.;Jwing testing in

A
ordec to

r~auce

confirmati~n

n e u r opsyc~cl0gical

the confounding effect of

biases .
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Chapter I:I
Resuli:s
Results of the PANSS indicated that the range of
positive and negative symptom p rese ni:ation va=ied from 0 to
6 items reported and 1 to 6 iLems reported under the
general symptom index .

All pari:icipants were identified as

having some symptom presentation related to their disorder
with in the last 6 months .

rn:ormation regardin;

medication treatment indicated that the range of typical
dosage varied from 0 mg to 150 mg

(~

=

=

25 . 97 , SD

48 . 81) ,

and atypical medication dosage varied from 0 mg to 160 mg
(M

==

17 . 56 , SO== 34 . 38) .
All participants in the experimental group revealed

some level of impairment in e;<ecuti ve functionir:g as
evidenced by results obtained by the WCST-64 .

Only 3

participants successfully completed 3 cai:egories . Of these
scores , all 3

par~icipar.t ' s

scored a percentile

>16 . Table 1 shows the scores of the

~3nk

par~icipar:~s

of

in the

experimencal group on each ir:dex of the WCST - 64 as divided
ini:o qualifiers
( no impairment )

ra~gi~g

from severe

impair~eni:

c~

a?e=age
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~

Table 1

Number of participants in the

expe~imental

group who scored

in each qualifier of the WCST-64 .

Qualifiers

Index

severe

moderate

TE

(N=l)

( N=5 )

(N=7)

(N = O)

(N = 3)

(N=4)

PR

(N=l)

(N=O)

(N=4)

(N = 4)

(N = S)

(N = 6)

PE

(N=2)

(N=l)

(N=7)

(N= 2)

(N = S)

(N=3)

NE

( N=l )

(N = O)

(N = 9)

(N=6)

(N =2 )

(N = 2 )

CL

(N=3)

(N=3)

(N=6)

{N=S)

(N=2)

(N=l)

mild/~oderate

mild *below average

*average

TE: = Total Errors, PR = Perseverative Respcnse , PE = Perseverati'1e
Errors , NE= Nonperseveracive Errors, and CL = ConcepLual Level
*below average and average index represent3 no :mpairmen:.

Note.

Only one member of the control group exhibited any
level of impairment with executive functioning as evidenced
on the WCST-64 .

All but one participant completed 3 er

more categories and scored a learning to
score >16 .

lear~

Table 2 shows the scores of che

on each index of
qualifiers as

~r.e

~he

WCST - 64 as divided

exper~men~a:

~rcu7.

in~o

percentile

contro~

~~oup

:he same

A neur~psycho~ogical perspec~i~e 29
Table 2

Number of participants in the control group who scored

i~

each qualifier of the WCST-64 .

Qu2lif ie.::-s

Index

severe

mild / moderace

mi:d *below a7erage *average *above

av~.

TE

(N = l)

(N=O)

(N = O)

(N=O)

01 =7 )

(N=6)

PR

(N=O)

(N = O)

(N=O)

(N=l)

(N=l3)

( N= 6)

PE

(N = O)

(N=O)

(N=O)

( N= l )

{N=6)

(N=:.3}

NE

(N=l}

(N = O)

(N = O}

{N=l)

( N= l :!. )

( N= 7)

CL

( N=l)

(N=O)

(N=O)

( N=l)

(N =l5 )

(N=3 )

= Total Errors, PR = Perseverative Response, PE "" P-:rseverative
Errors , NE= Nonperseverative Errors, and CL = Conceptua: Lavel
*below average , average, & above average index represen:s no ~mpa:r~ent .

Note . TE

Results of

2

Pearson Correlation revealed that there

was a significant relationship between medication type and
perf0rmance on the Failure to Maintain Set index of the
WCST - 64 . Those participants with

low e~

levels of atypical

medlcation were less able to mainLain set thar- those with
highe~

levels of atypical medication .

re9resented in Table 3 .

Res11l cs are

A
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Tab:e 3 .

Results of a Pearson Correlation for medication

~ype

and

performance on the WSCT - 64 .

.. .
'T'
.
_ype
Me d icaLior:

Typical

Index

Atypical

cc

-. 111

fM

-. 265

TE

-. 180

-. 117

PE

-. 022

- . 266

2R

-. 166

. 257

NE

. 225

. 329

CL

-. 222

-. 052

TC

-. 095

-. 208

TF

-. 227

. 143

- . :;_93

. 493*

TE = Total Errors, PR = Perseverac.:.ve !<.esponse , PE =
?erseverat.:.ve Srrors , NE = Nonperseverative Srrors, a~d CL = Conceptual
Level , CC = Categories Completed , E"M = E"a2.lure co i\/!ai.'.'.t:ain S~t, 'I'C: =
To~a: Number Correc~ , and TF = Tria:s to Complete firs~ Trial.
Note.

*significan~

at p < . 05 .

Resu~ts
wer~

of a Pearson Correlation revealed

no significant

rela~ionships

betNeen

symptom presentation and performance on
Results are represen ted in table 4 .

~~at

there

predcmi~ant

~~E

WCST-64 .

~erspec:.~ve

A neurcpsychologisal
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Table 4
Resulcs of a Pearson Corre2aticn for symptom pres2ncacion

and performance on the WCST-64 .

Sym~Lvrn

? .::-'=sem:a i: ior.

Index

?ositive

cc

- . 1 76

-. 316

- . 375

. 1 01

- . 273

. 238

TE

-. 118

. 002

. 017

PR

- . 137

-. 265

- . 22l

PE

- . 145

-. 248

- . 158

NE

. 069

-. 176

- . 047

CL

- . 134

- . 365

- . 266

TC

. 073

- . 404

- . 065

Tf

-. 216

- . 196

. 076

f

M

Nega:.:.ve

General

Note . TE = Total Errors , PR = Perseverar.ive Response, PE =
Perseverat~ve Errors , NE = Nonperseverative Errors , and C~ = Cor.ceptual
Leve~ , CC = Categories Completed , FM = Failure to Mair.tain Se~, TC =
Total Nwnber Correct , and TF = Trials to Comple:e First Trial.

Signif:_cant di:ferences were foGnd en all WCST - 64

between :he

con~=o!

group and the

Results of a t-cest for
i.!l L.able 5.

e~per:.mencal

independen~

means are

group .
rep~esen~2d

A

r.europsycho~ogica~

Table 5
Cescriptive statistics for the experimencal and control
group/s

perfor~ar-ce

on each index o: the WCST-64 .

Ccntrol Group

Exoeriment:a.'.. Grcuo

SD

:nde:<

SD

M

M

'i'

Sec re

TE

13 . 09

10 . 45

23 . 75

67 . 40

-9 . 38.,.

PR

16 . 69

19 . 30

24 . 83

58 . 20

- 5 . 81*

PE

17 . 55

18 . 15

24 . 83

67 . 50

- 7 . 25-.c

NE

23 . 22

16 . 45

25 . 08

51. 20

- 4 . 54*

c:.,

9 . 61

7 . 15

22 . 54

49 . 95

- 7 . 80*

cc

5 . 67

7 . 30

1. 78

15 . 60

- 6 . 23*

FM

. 76

. 80

. 41

. 20

TC

11. 35

31. 20

7 . 28

52 . 40

- 7 . 02 "

TF

6 . 62

9 . 75

. 97

15 . 30

-3 . 70*

3 . 08 *.,..

Noce. TE = Total Errors ,

PR = Perseverative Response , PE =
Perseverative Errors, NE = Nonpersevera=ive Errors , and CL = C0ncep~ual
Leve:, :c = Categor~es Com~let~d, c~ = :ai:ure co ~a~~cai~ Se~, TC =
Toed_ Number Correc~, and TF = ~r~als to Complete f~rs~ Trial .
*S.!.gn~f.:.cant

a;: p <. • 001 ,

• •Signi::..cant: at p < . 005 .

A ParLial CorrelaLion

deLermine che

co~ld

not be

combi~ed re:a~ionship

conduc~ed

of sympLom

to

prese:. ~a L~~r.

and performance on the WCST-64 due to the insignif icanL
r~sul;:s

found with 1:he Pearson Correiation betweer:. svmoi:)m

p~esentat~Jn

and

per:or~ance

on che WCST-64 .
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A Linear Regression co determine possible main ef feCLS
and interactions of medi c ation

~ype

could

~ot

due to the small sample size of this study .

be conducLed

Chapt~r

IV

Discussion

Results from chis study indicated that the WCST - 64
successfully de!ineated tetween

c~e

experime~:al

concrol group , however the ef:icacy o=

and

medicat~on

c~e

~reacme~c

for chronic schizophrenia could not be ascertained .

A

signi f icant correlaticn between medicat i on treatment and
perf o~mance or:

~he

WCST - 64 was found only between th e

fai : ur e to Maintain Sec index and acypical

medica~ion .

This index measures participancs
i nab i l i ty to complec e a category afte r completing 5
successful trials .

One ' s failure to maintain set

represents an inability to sore cards

s~ccessfully

~hrough

changing stimuli a:te r escabiishing the cor=ect matching
principle (Heaton et . al 2000) .

S kills required in

successfully maintaining sec may encompass many of the
defining features
is a

der~n~~ion

descr ~ bes

o:

execut~ve

funccion~ng .

Mose

by Craft ec . al (1989 , p . 345 ) , which

executive functioning as che '' abilicy co get into
mainta~n

the appropriate response set for a given task ,
chac
st~ay

se~ ,

per~ine~t

and to snift as needed . n

suggest

:na~

a:ypical

T~e

medica:~cn

res~lts

may be

of chis

~f~icacio~s
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on

improvi~g

inicial

t~is

hypot~eses

Overall ,

abiii:y among

sch~z~phre~ics

and

suppor~s

of this SLudy .

limiced findings of this study may be

explained by first , the levels of cognitive

impa~rment

among the experimental group may have been too severe to
delineate any within group variability .

Second ,

in orde r

to thoroughly address executive fJnc=ioning , a more
comprehensive neuropsychological bactery should be
considered .

Finally , the small sample size of this study

may have masked some pocentially significant results .

The

relationship o f symptom presentation and medication
treatment on performance on the WCST - 64 could r.ot be
computed , along with possible main effeccs and inceractions
of

med~cation

cype , as a result this

limi~ed

sample size

and insignificanc findings of a Pearson Correlacion .
As was expected ,

the WCST - 64 effectively delineated

cognitive impairment between the experimentaJ and control
group .

This finding strengchens

regardi~g

its

cogr.i~ively

e::~cacy

impaired

prev~cus

of distinguishing becween

par~icipan~s .

311 of :he icerns on cr.e

assumptions

~SCT-64

Per:ormar.ce on a:most

were f ou nd co be

significancly worse for the experimenca: g=oup than with
t~e

contro: group .
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Future studies of this nature may show more valid and
generalizable results by an increased sample size .
Increasing the number of neuropsycho l ogical teSLS used may
also provide a richer profile of executive

f~ncLioning

and

potentially present a greater variaLion of cognitive
impairment among schizophrenic participants . Since a
baseline of cognitive functioning prior LO tte introduction
of medication trea tmen t

for each participant in the

experimental group was not established, assumptions which
minimizes the benefits of atypical medication over typical
medication may be erroneous .

Future researchers may

consider establishing baselines of cognitive functioning
and designing longitudinal studies which may lead to more
conclusive findings .
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